Le‐Tian Huang

901 total citations
51 papers, 593 citations indexed

About

Le‐Tian Huang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Le‐Tian Huang has authored 51 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Le‐Tian Huang's work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Le‐Tian Huang is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Le‐Tian Huang collaborates with scholars based in China, Taiwan and Italy. Le‐Tian Huang's co-authors include Cheng‐Bo Han, Jie‐Tao Ma, Shuling Zhang, Li Sun, Jiahe Wang, Jiahe Wang, Wei Jing, Yijia Guo, Jun Song and Yanru Wang and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Le‐Tian Huang

44 papers receiving 583 citations

Peers

Le‐Tian Huang
Jiannan Liu China
Charles Lin Australia
Anna Eisenstein United States
Hyebin Lee South Korea
Laurence Goethals Belgium
Gabriel Krigsfeld United States
Mingyuan He China
Cheng Zhou China
Hongling Zhang China
Jiannan Liu China
Le‐Tian Huang
Citations per year, relative to Le‐Tian Huang Le‐Tian Huang (= 1×) peers Jiannan Liu

Countries citing papers authored by Le‐Tian Huang

Since Specialization
Citations

This map shows the geographic impact of Le‐Tian Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le‐Tian Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le‐Tian Huang more than expected).

Fields of papers citing papers by Le‐Tian Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le‐Tian Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le‐Tian Huang. The network helps show where Le‐Tian Huang may publish in the future.

Co-authorship network of co-authors of Le‐Tian Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Le‐Tian Huang. A scholar is included among the top collaborators of Le‐Tian Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le‐Tian Huang. Le‐Tian Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Le‐Tian, et al.. (2025). Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets. Neural Regeneration Research. 20(12). 3574–3590. 2 indexed citations
2.
Xu, Hongyi, Minjie Liu, Le‐Tian Huang, et al.. (2025). Enhanced Dielectric Loss via Six‐Coordinated Er Single Atoms on Porous Carbon Nanofibers for High‐Performance Electromagnetic Wave Absorption. Advanced Functional Materials. 35(32). 17 indexed citations
3.
Huang, Le‐Tian, et al.. (2024). First-line treatment of EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis. Scientific Reports. 14(1). 22901–22901. 1 indexed citations
4.
Sun, Li, et al.. (2024). Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study. JTO Clinical and Research Reports. 6(2). 100780–100780.
5.
Ma, Jie‐Tao, Jun S. Song, Xiaofang Yi, et al.. (2024). Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer. Cancer Immunology Immunotherapy. 73(2). 40–40. 4 indexed citations
6.
7.
Zhang, Shuling, Li Sun, Le‐Tian Huang, et al.. (2024). Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells. Molecular Cancer. 23(1). 260–260. 23 indexed citations
8.
Huang, Le‐Tian, et al.. (2024). Comparative effectiveness of ehealth self-management interventions for patients with heart failure: A Bayesian network meta-analysis. Patient Education and Counseling. 124. 108277–108277. 4 indexed citations
9.
Huang, Le‐Tian, et al.. (2023). Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells. BMC Complementary Medicine and Therapies. 23(1). 130–130. 4 indexed citations
10.
Zhang, Fei, Le‐Tian Huang, Minglin Li, et al.. (2023). Effect of Pre-Operative Low Serum Pre-Albumin on Surgical Site Infection in Post-Surgery Subjects: A Systematic Review and Meta-Analysis. Surgical Infections. 24(8). 684–691. 2 indexed citations
11.
Liu, Jiye, et al.. (2023). Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis. Oncology Letters. 26(1). 283–283. 6 indexed citations
12.
13.
Huang, Le‐Tian, Shuling Zhang, Cheng‐Bo Han, & Jie‐Tao Ma. (2022). Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer. Lung Cancer. 166. 9–16. 24 indexed citations
14.
Sun, Li, Yijia Guo, Jun Song, et al.. (2021). Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials. Frontiers in Oncology. 10. 586596–586596. 48 indexed citations
15.
Ma, Jie‐Tao, Yijia Guo, Jun Song, et al.. (2021). Rational Application of First‐Line EGFR‐TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR‐Mutant Non‐Small‐Cell Lung Cancer: A Systematic Review and Meta‐Analysis. BioMed Research International. 2021(1). 8850256–8850256. 5 indexed citations
16.
Sun, Li, et al.. (2019). The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs. Translational Cancer Research. 8(5). 1834–1844. 1 indexed citations
17.
Huang, Le‐Tian, Jie‐Tao Ma, Shuling Zhang, et al.. (2019). Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report. Frontiers in Oncology. 9. 1453–1453. 15 indexed citations
18.
Ma, Jie‐Tao, Xiangyan Zhang, Rui Cao, et al.. (2019). Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer Cells. Journal of Cancer. 10(17). 4045–4053. 23 indexed citations
19.
Guo, Yijia, Rui Cao, Xiangyan Zhang, et al.. (2019). <p>Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer</p>. OncoTargets and Therapy. Volume 12. 10343–10360. 36 indexed citations
20.
Ma, Jie‐Tao, Cheng‐Bo Han, Wei Jing, et al.. (2012). Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells. Oncology Letters. 4(3). 529–533. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiannan Liu Breakdown of academic impact, for papers by Charles Lin Breakdown of academic impact, for papers by Anna Eisenstein Breakdown of academic impact, for papers by Hyebin Lee Breakdown of academic impact, for papers by Laurence Goethals Breakdown of academic impact, for papers by Gabriel Krigsfeld Breakdown of academic impact, for papers by Mingyuan He Breakdown of academic impact, for papers by Cheng Zhou Breakdown of academic impact, for papers by Hongling Zhang
Rankless by CCL
2026